Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Carducci

Showing results (11-20 of 322) with videos related to

Pageof 33
Sort By:
Clinical Prostate Cancer|January 8, 2005
Early use of chemotherapy in conjunction with radical prostatectomyJoshi J Alumkal, Michael A Carducci
Expert Opinion on Investigational Drugs|January 6, 2010
Combining low-dose cyclophosphamide with GM-CSF-secreting prostate cancer immunotherapy enhances antitumor immune effectsEmmanuel S Antonarakis, Michael A Carducci
Expert Opinion on Investigational Drugs|August 18, 2018
Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directionsPedro Isaacsson Velho, Michael A Carducci
Expert Opinion on Investigational Drugs|November 30, 2002
Pharmacological treatments for prostate cancerJanet R Walczak, Michael A Carducci
Urology|May 12, 2005
Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trialsMichael A Carducci, Peter R Carroll
Seminars in Oncology|October 23, 2003
Endothelin receptor antagonists in the treatment of prostate cancerLance K Lassiter, Michael A Carducci
Urology|January 30, 2004
Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), Intergroup/Clinical Trials Support Unit studyJanet R Walczak, Michael A Carducci,
The Canadian Journal of Urology|July 16, 2005
Advanced prostate cancer: the futureAndrew J Armstrong, Michael A Carducci
Mayo Clinic Proceedings|February 13, 2007
Prostate cancer: a practical approach to current management of recurrent diseaseJanet R Walczak, Michael A Carducci
Current Opinion in Urology|May 9, 2006
New drugs in prostate cancerAndrew J Armstrong, Michael A Carducci
Pageof 33

Showing results (11-20 of 322) with videos related to

Sort By:
Pageof 33
Clinical Prostate Cancer|January 8, 2005
Early use of chemotherapy in conjunction with radical prostatectomyJoshi J Alumkal, Michael A Carducci
Expert Opinion on Investigational Drugs|January 6, 2010
Combining low-dose cyclophosphamide with GM-CSF-secreting prostate cancer immunotherapy enhances antitumor immune effectsEmmanuel S Antonarakis, Michael A Carducci
Expert Opinion on Investigational Drugs|August 18, 2018
Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directionsPedro Isaacsson Velho, Michael A Carducci
Expert Opinion on Investigational Drugs|November 30, 2002
Pharmacological treatments for prostate cancerJanet R Walczak, Michael A Carducci
Urology|May 12, 2005
Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trialsMichael A Carducci, Peter R Carroll
Seminars in Oncology|October 23, 2003
Endothelin receptor antagonists in the treatment of prostate cancerLance K Lassiter, Michael A Carducci
Urology|January 30, 2004
Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), Intergroup/Clinical Trials Support Unit studyJanet R Walczak, Michael A Carducci,
The Canadian Journal of Urology|July 16, 2005
Advanced prostate cancer: the futureAndrew J Armstrong, Michael A Carducci
Mayo Clinic Proceedings|February 13, 2007
Prostate cancer: a practical approach to current management of recurrent diseaseJanet R Walczak, Michael A Carducci
Current Opinion in Urology|May 9, 2006
New drugs in prostate cancerAndrew J Armstrong, Michael A Carducci
Pageof 33